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Standards-based, computable knowledge representations for eligibility criteria are increasingly needed to
provide computer-based decision support for automated research participant screening, clinical evidence
application, and clinical research knowledge management. We surveyed the literature and identiﬁed ﬁve
aspects of eligibility criteria knowledge representation that contribute to the various research and clinical
applications: the intended use of computable eligibility criteria, the classiﬁcation of eligibility criteria, the
expression language for representing eligibility rules, the encoding of eligibility concepts, and the mod-
eling of patient data. We consider three of these aspects (expression language, codiﬁcation of eligibility
concepts, and patient data modeling) to be essential constructs of a formal knowledge representation for
eligibility criteria. The requirements for each of the three knowledge constructs vary for different use
cases, which therefore should inform the development and choice of the constructs toward cost-effective
knowledge representation efforts. We discuss the implications of our ﬁndings for standardization efforts
toward knowledge representation for sharable and computable eligibility criteria.
 2009 Elsevier Inc. All rights reserved.1. Introduction
In clinical research, eligibility criteria are speciﬁcations of the
clinical and other characteristics of patients for whom a research
protocol might be applicable. According to the deﬁnition from Clin-
icalTrials.gov (http://clinicaltrials.gov/), eligibility criteria for clini-
cal trials are ‘‘the medical or social standards determining whether
a person may or may not be allowed to enter a clinical trial; they
are based on such factors as age, gender, the type and stage of a
disease, previous treatment history, and other medical conditions”.
Similarly, condition criteria are one of the key representation prim-
itives in computer-based clinical practice guideline models [1].
Since the requirements and issues surrounding the representation
of clinical research eligibility criteria are virtually the same as
those encountered in modeling condition criteria for clinical prac-
tice guidelines, both are referred to as eligibility criteria from this
point on in this paper.
Eligibility criteria are usually written in free text to be human-
readable; therefore, they are not amenable for computational pro-
cessing. As electronic health record (EHR) systems become broadly
adopted, standards-based, computable knowledge representationsll rights reserved.
omedical Informatics, Colum-
10032, USA. Fax: +1 212 305for eligibility criteria are increasingly needed to convey unambig-
uous logical statements to provide decision support for various re-
search tasks, such as matching eligible patients to clinical trials,
matching patients to applicable clinical evidence, and re-use of eli-
gibility criteria from related clinical research studies on similar pa-
tients during the design of a new study. Appropriate uses of
standards and computational formalisms are the two important
desiderata of computer-based eligibility criteria, where comput-
ability can be achieved at three levels: the syntactic, semantic,
and knowledge level [2]. Despite advancements in computable
representations of clinical guideline and electronic clinical trials
management systems (CTMS), knowledge representations for eli-
gibility criteria generally have not been robust enough to be exe-
cutable by computer [3], nor have they been represented in a
consistently generic manner [4]. There is no consistent practice
of ‘‘knowledge representation for eligibility criteria” [5]. In fact,
knowledge representation has been used to indicate computer-
based classiﬁcations of eligibility criteria content, standardization
of the syntactic forms of eligibility criteria, or standardization of
eligibility criteria terminologies. Existing knowledge representa-
tions for eligibility criteria vary in their underlying conceptualiza-
tions of eligibility criteria, and in their uncoordinated uses of
standards to represent medical concepts and uses of expression
languages to model eligibility rules. To our knowledge, there is
no comprehensive review that summarizes the state-of-art in
this domain. Meanwhile, a number of groups are developing
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Eligibility Rule Grammar and Ontology (ERGO) [6], the Clinical Re-
search Filtered Query (CRFQ) [7], and the Agreement on Standard-
ized Protocol Inclusion Requirements for Eligibility (ASPIRE) [8].
In this paper, we survey the literature and develop a conceptual
framework of ﬁve dimensions that support a structured compari-
son of various knowledge representations for eligibility criteria.
We also discuss the implications of these results for ongoing and
future standardization efforts toward generalizable knowledge
representation for clinical research eligibility criteria.
2. Methods
We used the PubMed Central and Google search engines to
identify relevant publications published by August 2008. Since for-
mal eligibility criteria representations were primarily embedded in
computer-based clinical practice guidelines or clinical trial proto-
cols, we used the following parenthesized phrases one a time to
conduct the search and aggregate all relevant manuscripts:
(‘‘ontology” AND ‘‘eligibility criteria”), (‘‘automated patient screen-
ing”), (‘‘computer-interpretable clinical guidelines”), (‘‘matching
patients to clinical trials”), and (‘‘knowledge representation” AND
‘‘eligibility criteria”). We also reviewed the references of each in-
cluded manuscript to identify related work missed by the above
queries.
3. Results
We retrieved publications for a total of 27 models or systems
with computer-based eligibility criteria knowledge representa-
tions. Some models and systems were described by multiple
publications over time; in those cases, we reviewed all the pub-
lications. We analyzed this body of work from ﬁve perspectives:
(1) the use case of eligibility criteria knowledge representation;
(2) the conceptual classiﬁcation of eligibility criteria; (3) the
choice of expression and query languages; (4) the encoding of
medical concepts; and (5) the modeling of patient data. We also
reviewed the domain speciﬁcity and uptake status of the identi-
ﬁed systems. Expression and query languages model the logic of
the relationships between the medical concepts used in eligibility
criteria, while patient information models support inference
using various medical concepts in reference to typical patient
information representations in EHR. The details of these 27 mod-
els are summarized in Appendix Table 1, and summarized below.
3.1. Use cases for eligibility criteria knowledge representation
Computer-based knowledge representations of eligibility crite-
ria have been designed to support three major use cases, described
below, that support tasks in both clinical research and clinical care
delivery.
3.1.1. Use case 1
Eligibility determination—ﬁnding clinical trials for which a pa-
tient is eligible [7–28], or identifying a cohort that is eligible for
a clinical trial. Example systems include OncoDoc [10,13], Onco-
Link [17], EligWriter [19], ASPIRE [8], caMatch [18], T-Helper
[26], EON [29], AIDS2 [20], OaSIS [30], PROforma [31,32], Asbru
[33,34], GLIF [35], SAGE [36], GUIDE [37,38], and PRODIGY [39].
Many of these systems were developed prior to the age of EHR.
In recent years, with the broad adoption of EHR systems, formal
eligibility criteria representations have become a crucial compo-
nent to data-driven clinical decision support solutions, and prom-
ise signiﬁcant value for clinical and public health research. An
example is automated EHR-based clinical research subjects presc-reening. For large multi-site clinical trials, eligibility criteria prefer-
ably should be encoded once in a formal representation that is
interoperable with different EHR systems at multiple sites. Also,
many surveillance systems use locally hard-coded criteria to select
populations and to allow the monitoring of important health mea-
surements for selected populations.
3.1.2. Use case 2
Applicability determination—determining when clinical evidence
derived from a clinical study is applicable to a patient’s clinical care
or identifying the recommendations in clinical practice guidelines
that are applicable to a patient [26], based on the patient’s clinical
situation. Much of the evidence generated from clinical trials re-
search is underused because it is not amenable for computer-based
retrieval and processing and because it is difﬁcult to match a pa-
tient’s speciﬁc clinical situation to the populations studied in trials.
Sim has developed The Trial Bank [41] to improve the accessibility
and computability of clinical trials evidence modeling at ﬁne gran-
ularity levels.
3.1.3. Use case 3
Knowledge management of clinical research—providing struc-
tured representations for eligibility criteria to optimize automatic
classiﬁcation, retrieval, search, and re-use of eligibility criteria across
clinical research studies. There is a compelling need to query and
re-use eligibility criteria in order to accelerate the development
of new clinical research protocols and related clinical research doc-
uments (e.g., case report forms, data collection forms, training
materials, etc.). Related effort include EligWriter [19] and Design-
a-Trial [42] that supported the re-use of eligibility criteria during
clinical trial protocol authoring, as well as ERGO [6] and ASPIRE
[8] that support eligibility criteria annotation.
Essentially, use cases 1 and 2 are similar in that they both
match patient information to clinical research protocol or evi-
dence, while use case 3 is focused on supporting interoperability
among different clinical research studies. Use cases 1 and 2 can
both operate in two modes: (a) patient-driven mode (rank or ﬁlter
clinical protocols one patient a time) or (b) protocol-driven mode
(rank or ﬁlter patients one protocol a time) [20]. In mode (a), indi-
vidual patient data can be acquired from manual data entry or ex-
tracted from EHR systems; in mode (b), patient data are usually
extracted from an EHR or Personal Health Records (PHR) system
and automatically matched to computer-based eligibility criteria.
The use of EHR or PHR systems requires semantic matching be-
tween representations of eligibility criteria and representations
of patient data in EHR or PHR systems, which is an active research
area with challenges such as the semantic gap between eligibility
criteria and patient data as ﬁrst identiﬁed by Chute [43], and the
need for complex aggregation and inference over both structured
and free-text patient data [44].
Some knowledge representations have been designed to serve
multiple use cases. For example, ASPIRE and EligWriter are both
designed to support use cases 1 and 3. To date, use case 1 is the
predominant (87%) use driving the formal knowledge representa-
tion of eligibility criteria. Among the systems designed to support
use case 1, Fink [15] and Ohno-Machado [20] generated recom-
mendations for additional data gathering tests to minimize uncer-
tainty related to patient eligibility status based on the descending
order of associated test costs.
3.2. Classiﬁcation of eligibility criteria
We observed great variation in approaches to characterizing eli-
gibility criteria across different eligibility criteria knowledge repre-
sentations. The space of existing classiﬁcations of eligibility criteria
can largely be divided along three dimensions: content, use in eligi-
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ity criteria.
The ﬁrst dimension for classifying eligibility criteria deals with
the content—or the information needed to answer eligibility que-
ries. Along this dimension, subcategories of eligibility criteria in-
clude intent, main clinical category, and main medical topic [5].
By intent, criteria can be divided into inclusion criteria and exclu-
sion criteria. By main clinical category, criteria can be categorized
in many ways—typically by demographics, clinical ﬁndings, medi-
cal history, allergies, procedural or surgical history, behavioral
characteristics, laboratory data, device data, vitals, prior or con-
comitant medications, and administrative and informed consent
issues. By main medical topic, eligibility criteria can be separated
into disease areas, such as cardiovascular diseases, diabetes, can-
cer, and so on. Within each medical topic, criteria can be further
classiﬁed by ﬁner clinical details speciﬁc to the topic. For instance,
in the United Kingdom’s CancerGrid project [45], criteria for breast
cancer are be further classiﬁed by tumor size, stage, receptor sta-
tus, and so on.
Content-oriented classiﬁcations of eligibility criteria have been
popular and motivated by several different conceptualizations.
Van Spall et al. recently examined eligibility criteria from a ran-
dom sample of randomized controlled clinical trials published
in high impact journals, and found variability in the content
and nature of exclusion criteria across studies [46]. Their interest
was to look at the clinical, scientiﬁc, or ethical justiﬁcation for
exclusion criteria. They characterized the nature and constructs
of different eligibility criteria across the protocols that they sam-
pled. This classiﬁcation included age, sex, sex-speciﬁc conditions
such as menstruation, pregnancy, or lactation, race, ethnicity, reli-
gious background, language ability, educational background,
socioeconomic status, cognitive ability, physical ability or disabil-
ity, chronic health condition, and condition under investigation.
Sim et al. presented a summary of 1000 eligibility rules randomly
sampled from ClinicalTrials.gov [5] and found that the sampled
rules fell into three high-level constructs: 46% medical histories,
diagnoses, or conditions; 36% treatments; and 25% tests or proce-
dures performed and results. Metz et al. classiﬁed eligibility crite-
ria representations into demographics, contact information,
personal medical history, cancer diagnosis, and treatments to date
[17]. In the Trial Bank Project, Sim classiﬁed criteria into age–gen-
der rules, ethnicity–language rules, or clinical rules [41]. The AS-
PIRE project differentiates ‘‘pan-disease criteria” (e.g., age,
demographics, functional status, pregnancy, functional status,
etc.) from disease-speciﬁc criteria (as of 2008, only in the domain
of breast cancer and diabetes) [8]. The caMatch project is primar-
ily focused on eligibility criteria representations for breast cancer
[18]. Rubin et al. classiﬁed eligibility criteria by clinical states to
ensure that research protocols for patients at similar clinical
states would have similar eligibility criteria and to reduce the to-
tal number of criteria needed to author several clinical protocols
[27]. They developed 24 categories for classifying the eligibility
criteria from NCI’s Physician Data Query (PDQ) database and
found great redundancy in protocols for similar clinical states
[47]. Seroussi et al. also classiﬁed eligibility criteria according to
patient clinical states in the OncoDoc system [10].
A second dimension for characterizing eligibility criteria relates
to eligibility criteria properties that are useful for optimizing eligi-
bility determination. Such classiﬁcations often aim to reduce
uncertainty in eligibility or applicability, to minimize test costs,
or to reduce risks for patients involved in eligibility screening. In
the AIDS2 system, Ohno-Machado grouped criteria in three broad
categories: ‘‘history”, ‘‘examination”, and ‘‘tests”. For ‘‘tests”, she
classiﬁed eligibility criteria by their importance in determining eli-
gibility status for the protocol, risks imposed on patients, and cost
(including cost of objective tests and clinicians’ time to assess dif-ferent criteria) [20]. In the T-Helper system, Tu viewed a partici-
pant’s eligibility for a clinical protocol as a dynamic property
[48] and differentiated eligibility criteria by their objectiveness,
variability, and controllability of the underlying clinical conditions.
Based on this rationale, criteria were organized into ﬁve groups:
(1) stable requisite; (2) variable routine; (3) controllable; (4) sub-
jective; and (5) special. The stable-requisite criteria are precondi-
tions that are immutable, such as history of a disease, having
intolerance to certain drugs, or having received a prior treatment.
The variable routine criteria are criteria that depend upon data
that are relatively stable over short time periods (e.g., the results
of lab tests) and are collected routinely during patient care. The
controllable criteria involve patient circumstances that a physician
can modify. The subjective criteria involve a physician’s judgment.
Examples include the likely duration of patient survival or the Kar-
nofsky score for patient functional capacity. Finally, the special cri-
teria are those that depend upon the results of unusual lab tests
(often costly and invasive) that are not typically performed in
the context of routine care. Such tests should not be performed un-
til a patient is identiﬁed as a likely study candidate. An advantage
of Tu’s classiﬁcation is that prospectively, patients who are consid-
ered ineligible only because of variable routines or controllable cri-
teria can potentially become eligible later or when speciﬁc actions
are taken. Later, Papaconstantinous divided the criteria into two
classes: constant or variable, which can be seen as a simpliﬁcation
of Tu’s classiﬁcation method [9].
The third dimension of eligibility criteria classiﬁcation ad-
dresses the complexities of semantic patterns in eligibility criteria.
Fink et al. classiﬁed criteria into three types of questions: the ﬁrst
type takes yes/no response, the second takes multiple choices, and
the third requires a numeric answer [14–16]. In a more sophisti-
cated manner, in a review study of six representative computer-
based clinical guidelines (EON, Asbru, PROforma, GUIDE, GLIF,
PRODIGY) [49], Peleg et al. categorized eligibility criteria into pres-
ence criteria, template-based criteria, ﬁrst-order logic criteria, tem-
poral criteria, ‘‘if–then–else” statements, and context-dependent
expressions. A recent clinical guideline model SAGE [36] extended
previous work in clinical guideline modeling and similarly classi-
ﬁed eligibility criteria into presence criterion, N-ary criterion, goal
criterion, comparison criterion, temporal comparison criterion,
variable comparison criterion, and adverse-reaction presence crite-
rion. In guideline models, condition criteria can be classiﬁed by
their implications for the execution states of guideline actions or
plans. For example, Asbru deﬁnes six types of conditions, including
ﬁlter preconditions for a guideline to be applicable, set-up precon-
ditions to enable a plan to start, suspend-conditions that deter-
mine when an active plan instance has to be suspended, as well
as abort-condition, complete-conditions, and reactivate-conditions
[34].
The classiﬁcation of eligibility criteria is deﬁnitely a non-triv-
ial problem that introduces great variation in practice. We found
no prior study about the limitations or uses of existing classiﬁca-
tions for eligibility criteria. Ideally, with a formal knowledge rep-
resentation for eligibility criteria, all dimensions of eligibility
criteria (e.g., content such as clinical topics or medical concepts,
uses, features such as uncertainty for eligibility determination,
and so on) should be represented explicitly to enable automatic
and ﬂexible indexing, classiﬁcation, retrieval, and usage of eligi-
bility criteria.
3.3. Expression language for eligibility criteria
Expression language is a critical component of a knowledge
representation for eligibility criteria, because it serves to for-
mally model relationships between multiple concepts embedded
within eligibility criteria statements. Examples of relationships
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(e.g., ‘‘hypertension among men above 70 years old”). Languages of
varying expressiveness have been used to represent the logic of
eligibility criteria, including (a) ad hoc expressions; (b) the Arden
Syntax; (c) variants of logic-based languages, including the PAL
language in Protégé [50], the Structured Query Language (SQL)
[51], and description logic [52]; (d) object-oriented query and
expression languages, such as GELLO [53]; and (e) temporal
query languages, such as Asbru [34] and Chronus II [54]. The
above expression languages are compared below. The ‘‘Design-
a-Trial” system and OncoDoc both represent eligibility criteria
as text strings; therefore, they are excluded from this analysis.3.3.1. Ad hoc expressions
3.3.1.1. Description. The development of ad hoc expression lan-
guages is driven by use cases instead of any theoretical basis. In
contrast, the Structured Query Language (SQL) has a theoretical ba-
sis in relational calculus and GELLO has root in Object Constraint
Language, which has being given a formal foundation [55]. Exam-
ples of ad hoc expression languages include EON [29], SAGE [36],
and ERGO [41].
The simplest type of ad hoc expression languages deﬁnes a set
of parameters (e.g., Presence_of_Renal_Insufﬁciency, Sit-
ting_Blood_Pressure, and Menopausal_Status) that can take Boolean,
numeric, or enumerated values. The expression language provides
comparison and logical operators (e.g., ‘‘=”, ‘‘>”, ‘‘AND”) that allows
the construction of logical expressions (e.g., ‘‘Menopausal_Sta-
tus = Post-Menopaual AND Sitting_Blood_Pressure > 150”) that can
be evaluated in terms of raw patient data. Ad hoc expressions also
can be constructed using a rich information model of patient data.
In the latter approach, the expression languages assume relational
or object-oriented information models (e.g., HL7 RIM). A formal
syntax for ad hoc expressions allows the deﬁnition of queries, vari-
ables, and logical statements involving comparison, arithmetic
combinations, arbitrary conjunctions and disjunctions, as well as
temporal constraints on data records. Templates are often devel-
oped to assist the formulation of logical expressions by objectifying
patterns such as queries including a comparison between a nu-
meric entry (e.g., serum creatinine value) and a cut-off value
(e.g., 140 mm Hg), and (2) Boolean combinations of multiple
queries.
Generally, it is easier to convert eligibility criteria to simple
parameter-value ad hoc expression representations automatically
rather than to translate such criteria into representations based
upon computable and adaptable clinical data models, due to the
semantic and knowledge gap between eligibility criteria and clini-
cal data. For instance, ‘‘having major surgeries” may be represented
as a simple parameter with a yes/no value without having to spec-
ify ‘major surgeries’ and how they are documented in EHR (e.g.,
surgical data could be encoded by Current Procedure Terminology
[56] or textual surgery procedure names in patient reports). The
downside of such simple parameter/value representation, of
course, is that it mandates extra work to check eligibility by query-
ing existing EHR systems.
3.3.1.2. Expressiveness. The expressiveness of ad hoc expression
languages depends on the speciﬁc use cases driving the con-
struction of the language. Some eligibility criteria pose require-
ments for considerable expressivity (e.g., ‘‘average systolic blood
pressure over two consecutive encounters more than 2 months
apart is greater than 120”) [36]. In general, ad hoc expression lan-
guages have limited capability to use formal reasoning methods,
such as temporal constraint algorithms or predicate logic. Thus,
for example, an expression like ‘‘presence of an authorized medi-
cation that is contraindicated by some medical condition”) involvesa relationship (contraindication) between two variables (autho-
rized medication and medical condition). Without generic methods
for formulating relationships among variables, ad hoc expression
languages typically cannot handle such complex logical
expressions.
3.3.1.3. Uses. Templates for ad hoc expressions of eligibility criteria
are very popular and have been used broadly in OaSIS, OncoLink,
caMatch, ASPIRE, CRFQ, EON, SAGE, and ERGO and the clinical trial
screen system developed by Fink et al. at the University of South
Florida [14–16]. Ad hoc expressions for eligibility criteria were fur-
ther translated to SQL database queries in T-Helper. PROforma and
Asbru represent ‘‘presence criteria” as data items with a Boolean
value (‘‘yes” or ‘‘no”).
3.3.2. The Arden Syntax
3.3.2.1. Description. The Arden Syntax originates from the knowl-
edge encoding schemes of the Health Evaluation through Logical
Processing (HELP) system developed at LDS hospital in Salt Lake
City [57] and of the CARE system developed at Regenstrief Insti-
tute in Indiana for providing alerts and reminders [58]. It is not
a programming language, but a hybrid between a production
(‘‘if–then”) rule system and a procedural formalism. The Arden
Syntax for Medical Logic Modules (MLM) is a HL7 standard for
encoding medical knowledge and capturing condition–action
rules. Arden provides rich time functions and explicit links to
clinical data embedded in curly brackets that can support local-
ization of variables ﬂexibly. In addition, Arden has the concept of
a single primary time associated with data variables, which is
analogous to time-stamped data queries expressed as logical
expressions. Wang et al. extended Arden by using ‘‘start time”
and ‘‘end time” associated with all variables to represent time
interval and by adding structures that may have attributes
[12]. The extended Arden Syntax enables reasoning over the
relationships among clinical terms contained in eligibility
criteria.
3.3.2.2. Expressiveness. In comparison to ad hoc expressions, the Ar-
den Syntax offers enhanced expressiveness through its rich collec-
tion of operators and time functions, and procedural control
structures such as iteration. Arden does not provide declarative
properties or deﬁned semantics for making temporal comparisons
or for performing data abstractions (e.g., retrieving an episode of
uncontrolled blood pressure) [34]. Wang’s extended Arden Syntax
for eligibility criteria made incremental improvements by adding
‘‘structure data types”, ‘‘dot operator” (e.g., ‘‘CHF.severity”), and
an ‘‘enumerated data type” so that variables can only take on a va-
lue from a pre-deﬁned list.
3.3.2.3. Uses. The Arden Syntax is probably the best supported
expression syntax. Vendors who have developed Arden-compliant
decision support applications include Eclipsys Corporation,
McKesson Information Solutions, Siemens Medical Solutions
Health Services Corporation, and MICROMEDEX. Arden Syntax
was chosen as the representation language for an early version
of GLIF, which was referred to as the Guideline Expression Lan-
guage (GEL) [35]. Later it was used by Wang et al. [12], Ohno-
Machado et al. [11], and Lonsdale et al. [21] for representing clin-
ical trial eligibility criteria. Wang tested it on the PDQ database
and estimated that 90% of criteria could be encoded using this
syntax.
3.3.3. Logic-based languages
3.3.3.1. Description. Major computer-based guideline models,
including PROforma and GUIDE, use logic-based to represent deci-
sion criteria that contain more complex logic than ad hoc criteria,
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guages vary in their expressiveness. Here we brieﬂy analyze three
examples that have been used to represent eligibility criteria:
Protégé’s constraint language (PAL) [50], The Structured Query
Language (SQL), and description logic (DL).
PAL speciﬁes a subset of ﬁrst-order predicate logic written in
the Knowledge Interchange Format (KIF) syntax [59]. It supports
functions that test argument frames, as well as type-coercion
functions and a few arithmetic functions. A constraint or query
expressed in PAL consists of a set of variable range deﬁnitions
and a logical statement that must hold on those variables.
SQL uses a set of operators, such as SELECT, DELETE, and UP-
DATE, to interact with relational databases. Eligibility criteria are
conditions about patient data in clinical databases and can be di-
rectly encoded in a ‘‘where” clause in a SQL query. The syntax for
the where clause is simple: ‘‘where column operator value”. Col-
umn speciﬁes variables that represent patient data; operators
can be =, <, >, <>, <=, >=, between, like, and IN; value can be a single
value, a set of values, or a range. Multiple where clauses can be
used to join several tables. A SQL query can be directly issued on
a clinical database, but is hardly transferrable to other clinical dat-
abases with different schemas. It is expressive but has poor sup-
port for knowledge re-use or inference.
Description logic (DL) is a special subset of ﬁrst-order predi-
cate logic that provides tractable classiﬁcation reasoning over
concept deﬁnitions. Description logic can be used to formally
represent each criterion as a concept that has a necessary and
sufﬁcient formal deﬁnition to support computer-based reasoning
over eligibility rules. Using an example provided by Patel et al.
[24], ‘presence of hematocrit test’ can be represented as a concept
deﬁned as ‘‘$ assesses-sample.BloodTest Specimen ^ $ entity-
measure.Hematocrit”, which says that ‘presence of Hematocrit
Test’ is true if there is some ‘blood test specimen’ sample and
the entity measured is ‘Hematocrit’. The strength of DL is that
there are pre-built reasoners that can classify patients into cate-
gories described using the description-logic expressions.3.3.3.2. Expressiveness. The three types of logic-based languages
encountered in our review each have pros and cons in expres-
siveness, SQL and PAL assumes negations as failures in a closed
world view while DL makes open-world assumption, where
something may exist even if it is not known to the reasoning
system. The consequence is that DL expressions cannot have
aggregation operators like maximum, most recent, or average.
DL enables automated concept-based classiﬁcation reasoning
and query expansion when converting eligibility criteria to data-
base queries. Recent versions of DL, especially Web Ontology
Language (OWL) 2.0, allow speciﬁcations of transitive roles and
numeric comparisons. DL cannot be used to formulate expres-
sions such as ‘‘AST no greater than 5 times ULN” if the ULN
(upper limit of normal) and measured AST value are part of
the same patient record. SQL does not support as many ﬁrst-or-
der predicate logic functions as DL, but it is optimized for efﬁ-
cient processing of large data sets. PAL enables reasoning over
the relationships between clinical terms and between classes
and instances in knowledge bases.3.3.3.3. Uses. EON uses PAL to deﬁne decision criteria [60]. Butt
et al. used SQL to represent eligibility criteria and implemented a
real-time patient recruitment system for clinical trials studies
[22]. GUIDE also used SQL to represent decision criteria. Patel
et al. implemented a description-logic-based clinical eligibility
screening system [24], where eligibility criteria were represented
in OWL 1.0 as semantic queries over the New York Presbyterian
clinical data warehouse. This system does not support reasoningover temporal constraints and cannot query numeric comparison
criteria such as ‘‘SBP > 130 mm Hg”.
3.3.4. Object-oriented expression and query language
3.3.4.1. Description. At present, there is only one object-oriented
language for eligibility criteria: GELLO [53]. GELLO expressions
operate over objects, and operators of the language can be ex-
tended by user-speciﬁed methods deﬁned for classes of objects.
GELLO is based on the Object Constraint Language (OCL), a query
and expression language designed for writing constraints in a
UML model. GELLO uses an object-oriented information model,
such as a Virtual Medical Record model based on HL7 Reference
Information Model [35].
3.3.4.2. Expressiveness. In GELLO, users construct expressions using
typed data values, variables, queries, functions, collections, and
user-deﬁned classes. The expression language is strongly typed.
In order to facilitate the process of encoding and evaluation of
expressions and more importantly, to maximize the ability to share
such queries and expressions, GELLO includes basic built-in data
types while providing the necessary mechanisms to access an
underlying data model with all its associated classes and methods.
This is especially important in enabling decision rules and guide-
lines to successfully work with different data models, inasmuch
as classes and relationships speciﬁed can vary from one data model
to another [61].
3.3.4.3. Uses. Initially developed as part of the GLIF representa-
tion language [36], GELLO has been adopted as an HL7 and ISO
standard. It has gained support in the commercial sector where
vendors, such as Medical Objects in Australia [62] and InferMed
in United Kingdom [63], have implementations that are driving
GELLO’s further development. The GELLO query language has
been designed within the context of a guideline execution model
proposed in the HL7 CDSTC. This model proposes the use of a
VMR (Virtual Medical Record) that provides a standard interface
to heterogeneous medical record systems to construct decision
criteria by building up expressions with which to reason about
particular data features/values. These criteria can be used to pro-
vide alerts and reminders, guidelines, or other decision rules
[61].
3.3.5. Temporal query languages
3.3.5.1. Description. The representation of time within eligibility
criteria for clinical research protocols is an important challenge
[64]. While most implementations of SQL have date-time data
types with special operators, none of the logic-based languages
support sophisticated temporal reasoning. Requirements for tem-
poral knowledge representation for clinical trial protocols in-
clude the representation of (i) relative time information (e.g.,
events are relative to protocol time points such as ‘‘Baseline”
and ‘‘Day 1”), (ii) indeterminacy (e.g., ‘‘+/ 1 day”), (iii) cyclical
event patterns (e.g., ‘‘every 3 weeks”), (iv) both time points and
time intervals (e.g., ‘‘pre-study” and ‘‘treatment period”), and coa-
lescing of temporal intervals that satisfy some condition (e.g.,
duration of period when the dose of drug is >N). Also, single-
point time intervals, such as ‘‘follow-up” events where the
start-point or start date is known but the interval is ambiguous,
are very common in clinical research protocols. Many eligibility
criteria contain temporal constraints and require abstraction or
reasoning of temporal patient conditions. Some representations
for eligibility criteria do not explicitly support temporal queries
[14,15,20], while many others only support query over time-
stamped data [12,30,40,65].
Numerous groups have proposed temporal query languages
for managing clinical data in the past. Here, we reviewed two
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ing and evaluating eligibility criteria: Asbru [34], a constraint-
based language, and Chronus [66] and its successor Chronus II
[54] that adapted query languages developed by the temporal
database community. Asbru’s temporal expression language, with
its syntax speciﬁed using Backus–Naur form (BNF) [34], supports
the speciﬁcation of temporal constraints on the beginning point,
ending point, duration, and repeating patterns in parameter/va-
lue-type conditions which need to hold at a plan step to induce a
particular state transition in the plan instance. Chronus II adapts
the TSQL2 temporal query language [67] to extend the standard
relational model and the SQL query language to support temporal
queries that include temporal projection, joins, granularity conver-
sion, and coalescing. It provides an expressive general-purpose
temporal query language that is tuned to the querying require-
ments of clinical decision support systems.3.3.5.2. Expressiveness. Asbru excels in expressing temporal con-
straints among events. It is XML-based criterion language that al-
lows speciﬁcation of value set or ranges, context, and temporal
extent of parameters. However, Asbru does not use any standard
clinical terminology or patient information model; therefore, its
strength is limited to only temporal aspects. Chronus II adopted
features, such as temporal coalescing, that were developed in the
temporal database community that are not implemented in any
other expression language reviewed in this paper.3.3.5.3. Uses. Asbru was used in the Asgaard project [33]. Chronus II
was used in the ATHENA decision support system and some data-
mining projects at Stanford [68].3.3.6. Others
In addition to the above expression languages, Ohno-Machado
et al. represented eligibility criteria using the Bayesian Belief Net
mechanism and probabilistic methods to address the frequent
‘‘missing data” challenge in eligibility matching by representing
complex relationships among different variables in the AIDS2 sys-
tem [20], as did Cooper et al. in another screening system con-
nected to a clinical data repository [69]. Eligibility criteria were
represented as criteria nodes with probabilities on possible val-
ues. Every node in their belief network either represented a clin-
ical parameter (e.g., ‘‘Hemoglobin”) that was used in a criterion
(e.g., ‘‘Hemoglobin > 11”), or represented a clinical data element
(e.g., ‘‘Anemia”), which differed from a clinical parameter in that
it inﬂuenced other nodes. These inﬂuences were expressed as
probabilistic dependencies (e.g., probability that hemoglobin > 11
given that the patient has clinical signs of anemia). The values of
nodes in the network could be either unknown or set to a partic-
ular pre-deﬁned state. If the state of a node was known, the prob-
ability of that state was 1.0, whereas the probabilities of all other
states were 0.0. If the node value was unknown, the network was
used to compute a posterior distribution conditioned on all nodes
that have a relationship with the node being observed. AIDS2
determined the patient eligibility status based on each criterion
by examining the value of the corresponding belief-network crite-
rion node. The patient eligibility for each criterion was repre-
sented by a probability, which was the addition of the
probabilities of all mutually exclusive states of the criterion node
that are considered to be eligible.3.3.7. Summary of expression languages
In summary, expression languages employed to represent eli-
gibility logic include ad hoc expressions (with or without the useof templates), the Arden Syntax, logic-based languages (i.e., PAL,
SQL, and DL), object-oriented languages (i.e., GELLO), and tempo-
ral query languages (e.g., Asbru and Chronus II). The next gener-
ation of clinical research systems that depend upon knowledge
representations for clinical research eligibility, whether they be
protocol authoring, clinical research results databases, study
metadata archives, patients screening, or public health (health
services delivery research), will require more robust expressive
languages. Ad hoc formalisms were functional and innovative
for the ﬁrst generation of systems processing eligibility criteria,
and have paved the way for our understanding of this complex
and vast area. SQL-based queries on a clinical database are more
expressive but not extensible for knowledge re-use or inference.
These mechanisms all suffer from the lack of scalability. We ob-
served that occasionally multiple query languages were used for
different types of logic within the same model or system. For in-
stance, EON used three languages to represent eligibility criteria
of different complexities [60], including (1) using ad hoc tem-
plates to encode common but relatively simple criteria by ﬁlling
in forms for presence criteria, comparison criteria, and Boolean
combinations of multiple criteria; (2) using PAL constraint lan-
guage to implement criteria that require reasoning over relation-
ships of medical concepts; and (3) using Chronus-II temporal
query language to encode complex criteria that require complex
reasoning over overlapping intervals for two events and coalesc-
ing of time intervals.3.4. Encoding of eligibility concepts
The expression language deﬁnes the syntax for specifying eli-
gibility criteria statements, and the eligibility concepts provide
the semantics. Olasov and Sim summarize the challenge of a rep-
resentation for computable eligibility criteria as having two ma-
jor components: (1) mapping terms within individual eligibility
rules to concepts in a controlled clinical vocabulary and (2) cap-
turing intended relationships between concepts and their modi-
ﬁers [4]. A sample of eligibility criteria from active studies in the
Rare Disease Clinical Research Network [70] was presented at
the 2007 AMIA symposium [5]. Of 452 eligibility criteria from
19 protocols (largely observational studies) on 22 diseases, the
majority of criteria (44%) represented clinical ﬁndings, which in-
cluded clinical diagnostic criteria, diseases, and symptoms. Al-
most half of the 452 eligibility items surveyed contained
multiple clinical concepts, e.g., ‘‘evidence of signiﬁcant chronic or
acute inﬂammation outside the lung such as connective tissue dis-
eases, panniculitis or acute infection”. Non-speciﬁc concepts are
often included in eligibility criteria, such as ‘‘Neurological illness”
or ‘‘Uncontrolled seizure disorders”. Laboratory measures might be
expressed in terms of their interpretation (e.g., ‘‘elevated sodium”)
or an institution-speciﬁc reference range (e.g., ULN for upper limit
of normal). The use of vague terms in clinical research protocols
is common and has been observed by Ohno-Machado et al. [20].
Therefore, an important component of eligibility criteria repre-
sentation is codiﬁed terminologies [71]. Computable eligibility
criteria representations should support reasoning over the
relationships among different concepts—particularly the determi-
nation of equivalence and subsumption between different
terms.
Some clinical trial recruitment systems use locally developed
medical concept classiﬁcations [20,21]. We observed that most
systems prior to year 1999, including ONCOCIN, T-Helper, AIDS2,
OaSIS, and some other unnamed systems [9,27], did not employ
any standard clinical terminology to encode medical concepts
in eligibility criteria, likely because clinical terminologies and
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(UMLS) [72] were still being developed and unavailable until
the late 1990s. Since 1999, the importance of using clinical ter-
minologies has been recognized in the literature as a critical
practice to support information interoperability, although no
wide-spread agreement on standards exists. Wang et al. noted
that the choice of a clinical vocabulary was tightly linked to
the implementation of a practical data-query and data-modeling
scheme [12], and used UMLS to extend the Arden Syntax for
representing clinical trial eligibility criteria. With the increasing
adoption of EHR and PHR since early 2000s, UMLS has been a
popular choice for encoding medical concepts in eligibility crite-
ria because of its interoperability with other medical terminolo-
gies and notable natural language processing software such as
MedLEE [73]. The Guideline Interchange Format (GLIF v3.0)
[35] used the UMLS to support clinical concept representation
as well. Similarly, Sim allows an option to map the clinical-rules
and the longest phrases in RuleEd to UMLS concepts [4]. LOINC
[74] was suggested as a candidate terminology for representing
concepts in lab results [75]. Although systems (e.g., Trialx [76])
have been developed to match clinical trials to PHR, to date,
there is no consumer health vocabulary available or in use for
encoding medical concepts in eligibility criteria to serve the
growing needs of clinical trial search initiated by health consum-
ers. The UMLS remains the popular choice for medical concept
encoding.
Another trend in encoding medical concepts in eligibility crite-
ria is using Common Data Elements (CDEs), which started with
Gennari’s use of the NCI’s CDEs to serve as a medical terminology
for oncology clinical trial protocols [19]. Later, ASPIRE and caMatch
also collaborate with CDISC in developing CDEs for encoding or
annotating medical concepts in eligibility criteria. Different from
UMLS, CDEs are standards for content and do not deﬁne formal
relationships among concepts, and hence do not provide inferential
capacity.
Perhaps because UMLS is too broad in scope for the focused
domain of eligibility criteria, the Systematized Nomenclature in
Medicine—Clinical Terms (SNOMED CT) [77] has been preferred
as the encoding terminology for clinical concepts by researchers
working on GUIDE, SAGE, ERGO, and others in recent years
[4,28,36,38]. One advantage of SNOMED CT is that it allows for
the creation and logical deﬁnition of new concepts using pre-
coordinated terms that already exist in SNOMED CT. The READ
codes [78] were another comprehensive clinical terminology
developed and used in the United Kingdom, and later merged
with SNOMED RT to produce SNOMED CT. The READ codes were
used in the PRODIGY clinical guideline model as the encoding
vocabulary [39].
Several systems used more than one terminology for different
data. For example, the current version of RuleEd (http://rct-
bank.ucsf.edu:9002/BaT/RuleEd.html) can map extracted clinical
phrases to either Medical Subject Headings (MeSH) [79] or
SNOMED CT. The SAGE model uses a suite of terminologies,
including SNOMED CT for clinical terms, LOINC for lab tests,
and the National Drug File—Reference Terminology (NDF-RT) for
drugs and related class information [80], and delineates three lev-
els of use (pre-coordination, post-coordination, and Boolean com-
binations) for standard terminologies for encoding and executing
clinical practice guideline knowledge bases.
Mapping from concepts (e.g., ‘‘patients with high blood pres-
sure”) to clinical data manifestations (e.g., ‘‘SBP > 140 mm Hg”) is
often not straightforward. Terminologies by themselves are insuf-
ﬁcient for helping us achieve automated matching between com-
putable eligibility criteria and EHR data for two primary reasons.First, concepts embedded within eligibility criteria can be under-
speciﬁed. For instance, there is no straightforward mapping for
‘‘chronic diseases” without manual and subjective selection of rel-
evant common chronic diseases such as diabetes, hypertension,
and so on. Second, there is a knowledge gap between concepts
in eligibility criteria and EHR data captured in speciﬁc clinical
contexts. For instance, an eligibility criterion may specify the con-
cept ‘‘renal failure”, while EHR data must be pieced together to
identify, for example, ‘‘an 80-year-old white female with serum cre-
atinine = 1.0 mg/dl”. There is no way to map ‘‘renal failure” to ser-
um creatinine value without knowing the patient’s age, gender,
ethnicity, and their relationship to renal failure. Therefore, termi-
nologies need to be used in combination with a patient informa-
tion model and relevant medical knowledge in order to facilitate
automatic matching between eligibility criteria and EHR data.
Some systems, such as OncoDoc, compensated this knowledge
gap by replacing underspeciﬁed terms. OncoDoc is a decision sup-
port system that assists physicians in deciding patient eligibility
for clinical trials. In OncoDoc, terms from controlled vocabularies
(e.g., UMLS, SNOMED CT, etc.) have not been used because they
were considered either too general or incomplete to take into ac-
count patient’s preferences and to support daily medical oncology
practice [13]. Instead, explicit deﬁnitions were created to com-
pensate for the ambiguity or incompleteness in these concepts.
For example, ‘‘cardiac function” in OncoDoc is expanded to be
‘‘good cardiac function (fractional shortening > 35% or ejection frac-
tion > 50%)” and ‘‘bad cardiac function (fractional shortening < 35%
or ejection fraction < 50%)”.3.5. Patient data modeling
Another important component of formal representations of
eligibility criteria—one as important as the use of controlled clin-
ical terminologies—is a patient information model that supports
the inference of medical concepts in reference to corresponding
patient data [71]. In order to serve the decision support use
cases identiﬁed earlier and to enable translation from eligibility
criteria to EHR-based patient data queries without knowing indi-
vidual EHR implementation details, representations of eligibility
criteria need to support standard-based modeling of patient
data, which is often through standard patient information mod-
els [1].
Systems developed prior to the year 2000 rarely used a patient
information model, but tended to deﬁne patient data as pairs of
parameters and values, where parameters represented the attri-
butes of patients, drugs, tests, and so on, and each value had an
associated time stamp that denoted when that value was ob-
served or a temporal interval when the value held true. Examples
include AIDS2, OncoLink, Fink’s system, the Arden Syntax, and
OaSiS. Systems developed after the year 2000 largely adopted
some form of Virtual Medical Records (VMR) [81] based on the
HL7 Reference Information Model (RIM) [82], which provides an
abstraction layer on top of a real EHR. Among the 27 knowledge
representations for eligibility criteria that we surveyed, nearly
half adopted a VMR, including GUIDE, GLIF3, SAGE, ERGO, CRFQ,
as well as Patel’s [24] and Lonsdale’s [21] systems, with varying
degrees of adoption. (For instance, only one ‘‘observations” class
from a HL7 VMR model was used in Lonsdale’s system.) Although
there is no consensus in the medical informatics community
regarding a standard patient information model, the development
of a VMR based on the HL7 RIM shows promise to mitigate the
classic site-speciﬁc data mapping problem (again, the ‘‘curly
bracket problem”).
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Many systems or models we surveyed are generic or domain
independent representations for condition criteria, though several
(ONCOCIN, OaSIS, OncoDoc, OncoLink, and caMatch), were speciﬁ-
cally designed for the cancer domain. ASPIRE was initially disease-
speciﬁc with a focus on breast cancer, but has been expanding to
other disease areas and includes domain independent (pan dis-
ease) data elements.
The adoption status of most of the models sampled in our re-
view is unavailable, primarily because they represent academic re-
search prototypes, which did not lead to real-world or wide-spread
adoption. Though uptake is hard to assess, it is clear that most sys-
tems we surveyed were implemented in single organization set-
tings. To our knowledge, EON, ERGO, PROforma, Asbru, OncoLink,
caMatch, ASPIRE, SAGE, and Arden Syntax are actively used in
ongoing projects. Among those, caMatch, ASPIRE, and OncoLink
are used in the following web-based patient recruitment systems
respectively: https://www.breastcancertrials.gor/bct, http://clini-
caltrials.cop.org/, and http://www.oncolink.com. OncoDoc has
been implemented at the Institute Gustave Roussy (IGR), known
as the ﬁrst European cancer research center, and routinely used
at the point of care during a 4-month period [10]. GELLO has been
adopted as an HL7 and ISO standard. Commercial vendors, such as
Medical Objects in Australia [62] and InferMed in United Kingdom
[63], have active implementations that are driving GELLO’s further
development.4. Discussion
In this study, we used a set of keywords to search the liter-
ature for existing knowledge representation for eligibility crite-
ria. We identiﬁed ﬁve aspects of eligibility criteria knowledge
representation that contribute to the existing heterogeneous ap-
proaches: the intended use of computable eligibility criteria, the
classiﬁcation of eligibility criteria, the expression language for rep-
resenting eligibility rules, the encoding of eligibility concepts, and
the strategy for modeling patient data. Each of these aspects
has a spectrum of options. We also consider three of these as-
pects—expression language, codiﬁcation of eligibility concepts, and
underlying model of patient data—to be essential constructs of
a formal knowledge representation for eligibility criteria.
Requirements for these three knowledge constructs vary for dif-
ferent use cases and eligibility criteria statements of different
complexities. It is feasible to combine multiple expression lan-
guages and multiple terminologies to achieve expressive and
interoperable eligibility criteria knowledge representations. Next,
we discuss the implications for related standardization efforts in
this area.4.1. A conceptual framework for organizing eligibility criteria
representations
Using the ﬁve knowledge constructs for eligibility criteria iden-
tiﬁed in this paper, uses of eligibility criteria knowledge represen-
tations can be categorized with respect to the expressiveness of
eligibility rule expression languages, the range of terminologies
for eligibility concept modeling, and the inclusion of a patient
model. Some use cases such as knowledge management do not re-
quire patient data modeling nor eligibility rules expression and
inference. For example, re-use of eligibility criteria during protocol
authoring does not require an expressive expression language or
patient data modeling. In contrast, use cases such as eligibilitydetermination or clinical evidence applicability determination re-
quire interoperability with patient data. The knowledge represen-
tation requirements for eligibility criteria in these contexts are
more stringent, including highly expressive language(s) to achieve
executable eligibility rules, a patient information model, and an
appropriate clinical terminology to facilitate mapping from eligi-
bility concepts to patient data. Applications that use eligibility cri-
teria to support indexing, classiﬁcation, and annotations of clinical
studies (e.g., ASPIRE and caMatch) require medium expressiveness
for representation languages—less than that required for applica-
tions designed for applicability determination but more expressiv-
ity than is required for protocol authoring. They do not need a
computable representation for a patient data model, but require
a representation for criteria that facilitates indexing, classiﬁcation,
and searching.
Appendix Table 1 shows that an expressive language is very
important for clinical decision support uses of formal representa-
tions of eligibility criteria (e.g., applicability and eligibility deter-
mination); a patient model is less important for uses such as
knowledge re-use in protocol authoring; and while a controlled
terminology is indispensible for all uses, the choice of a speciﬁc
terminology greatly depends on the use. Eligibility criteria
representations designed to support systems for applicability
determination may better use a literature-oriented terminology
such as MeSH to encode medical concepts, while representations
designed to support eligibility determination may better use a
clinically oriented terminology such as SNOMED CT. Because
terminologies have coverage of different domains and variable
structures, they are individually suited for particular uses and
should not be hard-coded in knowledge representations. Natural
Language Processing (NLP) of eligibility criteria can be used to
extract key eligibility concepts and support ﬂexible mappings
to a range of terminologies (e.g., MeSH and SNOMED CT);
RuleEd already supports this feature. Therefore, a formal knowl-
edge representation of eligibility criteria may better support a
component-based design to allow ﬂexible ‘‘plug-and-play” of
options for each construct suitable for different uses. Moreover,
Table 1 implies some dependencies among the choices and/or
needs for terminologies, patient data models, and expression lan-
guages. For example, representations that need patient data
modeling tend to need expressive query languages and a
clinically oriented terminology with coverage of patient data
(e.g., SNOMED CT).
We can cluster various eligibility representations by use
cases. The clusters that indicate similar representation efforts
should be harmonized. For example, there is a higher degree of
similarity between caMatch and ASPIRE than between ERGO
and ASPIRE; caMatch and ASPIRE share the same level of expres-
siveness in their query languages, while ERGO has a more
expressive query language than ASPIRE. Therefore, it is easier
to convert instances from ERGO to ASPIRE, but conversion in
the opposite direction is harder, because ASPIRE instances do
not specify computable rules for eligibility criteria while ERGO
uses a more expressive query language to represent eligibility
rules. Moreover, at present, the activities in the clinical research
cycle do not share a uniﬁed underlying eligibility criteria model.
The clinical research cycle includes multiple steps, including lit-
erature review, new research question identiﬁcation, protocol
authoring, subject recruitment, data collection (i.e., study con-
duct), and results publishing. Each step can be mapped to an in-
tended use of a formal knowledge representation for eligibility
criteria. At present, the uses of research protocol authoring and
management systems are the primary driving efforts for formal
representations of eligibility criteria. Practically, it may not be
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support all possible uses of computable eligibility criteria. On
the other hand, a use-driven knowledge representation design
principle (that allows for multiple representations) may create
discontinuity and barriers for a holistic and streamlined discov-
ery process because a user may have to use different knowledge
representations for various uses, such as searching literature,
authoring protocols, linking protocols to patient databases,
and publishing research results. The clinical research informatics
community may want to address this research challenge to-
gether and develop formal knowledge representations that
support translational research through the whole research life
cycle.
4.2. Standardization of eligibility criteria representations: challenges
and opportunities
Standards-based knowledge representation for eligibility cri-
teria is an active research area [83]. With the availability of rich
standards for each construct for formal knowledge representa-
tion of eligibility criteria, many researchers have been using
multiple standards in one representation. For example, EON used
three expression languages to represent eligibility rules. Concur-
rent uses of multiple standards may be a pragmatic solution, but
also contributes to the challenges of standardization and harmo-
nization in this domain. Fortunately, several high-proﬁle efforts,
including ERGO, ASPIRE, and CDISC, have been working collabo-
ratively to achieve community-wide agreements on related stan-
dards. We believe that representations within a given cluster
could be harmonized to reach community consensus, while rep-
resentations in different clusters will need interoperability sup-
port between each other. In the past decade, shared clinical
terminologies, standard patient information models, and stan-
dard expression and query languages have been increasingly
recognized as important tools for achieving interoperability
across health organizations. Although these goals are gaining
popular support, clearly there are signiﬁcant barriers to achiev-
ing them.
The challenges for standards-based encoding of eligibility
concepts are multifaceted. The complexity in clinical statements
is a key factor that causes the variant needs for a broad range
of expression languages. One single terminology often cannot
cover all the concepts embedded in eligibility criteria so that
multiple controlled terminologies for clinical ﬁndings, test re-
sults, labs, medications, or medications often need to be used
together. Additionally, it has been shown that there are certain
structural features and information facets of eligibility criteria
that are not fully represented by some terminology models
[84]. The Consolidated Health Informatics (CHI) standard [85]
for standardized Patient Assessment items and subsequent
Department of Health and Human Services (DHHS) standards
recommendations are based upon the premise that one stan-
dard (LOINC) is required to represent structural and question
administration features (e.g., unit, method, subject, period of
observation), and that additional clinical vocabulary is required
to represent the clinical concepts contained in the questions
[86].
In recent years, the latest standardization focus has been on
Common Data Elements (CDE), which serve as standard metada-
ta [87]. The National Cancer Institute (NCI) and the Clinical Data
Interchange Standards Consortium (CDISC) are developing CDE
repositories in support of standards-based clinical research activ-
ities. The CDEs are structured data reporting elements, consistingof precisely deﬁned questions and answers, which represent eli-
gibility criteria the same as any other research data element. The
uses of metadata and vocabulary standards for indexing eligibil-
ity criteria, in applications such as the NCI’s caDSR [88,89], could
drive better-authored eligibility rules (when investigators under-
stand how the questions will be indexed) and thereby improve
the re-use of existing eligibility criteria. Since such repositories
(also called metadata repositories or item banks) have only
emerged within the past few years, only a few recent formal
representation efforts of clinical eligibility criteria, e.g., including
caMatch and ASPIRE, have adopted and extended these CDEs.
The caMatch project includes collaborations with HL7, CDISC,
and OMG vocabulary-driven data entry to use CDEs from NCI’s
caDSR repository. However, there is a signiﬁcant difference be-
tween the ASPIRE approach and the caMatch approach. ASPIRE
uses CDE as metadata to index and annotate eligibility criteria,
instead of trying to capture the precise clinical statements repre-
sented by the criteria. In contrast, the caMatch approach uses
standard CDE terms to deﬁne eligibility criteria constructs. Both
approaches have advantages and disadvantages. In the ASPIRE
approach, comprehensive domain-speciﬁc data elements are clo-
sely connected to the retrieval accuracy of annotated eligibility
criteria.
It is advantageous in that a criterion can be ﬂexibly annotated
with multiple CDEs anytime. The CDEs then can be used to en-
able ﬂexible and dynamic multidimensional categorizations of
eligibility criteria, and consequently support their storage and
re-use. However, this approach does not deﬁne computable
expressions of eligibility criteria. The caMatch approach that uses
CDEs together with expression and query languages to represent
eligibility criteria can be expressive, but the expressiveness is
contingent on the coverage of the clinical terminologies and pa-
tient information models being used. A range of clinical terminol-
ogies are needed to collectively represent a variety of clinical
statements. Multiple clinical terminologies will be needed to sup-
port representation for different data sources, including lab tests,
medication, diagnosis, and free-text reports. While the NCI caDSR
is beginning to formally relate CDEs to the standardized termi-
nologies hosted by the NCI, there has been criticism on the com-
pleteness and validity of these relationships [87]. We consider
CDE and expression languages to be complementary for the
development of formal representation of eligibility criteria.
Expression languages can be used to organize CDEs to construct
computable eligibility criteria statements so that the CDEs can
be evaluated against EHR data. To leverage their complementary
strengths, a useful implementation of the CDE idea would be a
library of executable rules expressed in computable eligibility cri-
teria languages. Regardless, it is foreseeable that there will be cri-
teria that either cannot be formalized as computable expressions
or will not have EHR data to support automated evaluation of
CDEs.
During the natural evolution of methods and conceptualization
of formal representations for eligibility criteria, when no standards
existed, none were used; as standards began to emerge and multi-
ply, standards start to be used in various ways. Therefore, a recent
trend is also the standardization of the uses of standards, or stan-
dards best practice. We envision the harmonization of existing stan-
dards for expression languages, patient information models, and
supporting terminologies will inform best practices for the author-
ing of eligibility criteria and their formal representation. Robust
and harmonized representations for eligibility criteria can have
immediate impact on the speed of clinical research and improving
human health.
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Future work includes addressing the emerging needs from
public health informatics, consumer health informatics, and clin-
ical research informatics, improving interoperability and briding
the semantic and knowledge gaps between computable eligibil-
ity criteria and clinical data in EHR and PHR, and developing ter-
minology standards that can cover a broad range of users,
especially health consumers who may use lay language terms
to describe their medical situations and search for clinical evi-
dence or clinical research opportunities. It will not be a trivial
undertaking to make the next generation of eligibility criteria
representations fully standards-based and amenable to auto-
matic retrieval, agile classiﬁcations, indexing and re-use. Simi-
larly, bridging the semantic gap and using such representations
in heterogeneous EHR and PHR systems will require time, re-
sources, and intellectual input from a broad group of stakehold-
ers. As a rule, the ideal choices of standards should suit intended
use cases. For the same use case, related clinical research stan-
dards should be harmonized within the research community;
for different uses, representations should have interoperability
with each other. Efforts should be made to achieve a compre-
hensive, standards-based knowledge representation for eligibility
criteria that supports the full cycle of translational research,
from literature review, to protocol authoring, to trial recruit-
ment, and to study publishing. Therefore, knowledge representa-
tion for eligibility criteria should not be narrowly focused on one
of the above use cases but be expressive or ﬂexible enough to
support multiple use cases.
Based on the new emphasis from the DHHS on translational re-
search, interoperability between data systems and standards be-
tween health delivery and research will drive the requirements
for formalisms for eligibility criteria. Programmatic aims for
increasing the efﬁciency of clinical research (i.e., The NIH Roadmap
Initiative for Re-engineering the Clinical Research Enterprise)
intrinsically include requirements for scalability of systems—
which will depend upon standardized representations for eligibil-
ity. Harmonization—both within clinical research communities,
and across healthcare and public health communities, will be fruit-
ful. The quality and uptake of standards will require participation
and support of many stakeholders—researchers and systems devel-
opers, vendors and academia. The topic of formalized and stan-
dardized knowledge representation for eligibility criteria should
therefore be at the top of discussion agendas for clinical research
informatics stakeholders.4.4. Limitations
Our keywords list for the literature search may not have been
exhaustive and we might have neglected to consider some relevant
representations, especially those embedded in clinical decision
support systems without explicit references to eligibility criteria
representations. Moreover, some of the articles that we retrieved
did not have sufﬁcient details for condition criteria representa-
tions, and hence we could not review such systems’ representa-
tions as thoroughly as we would have liked. Further, our
depiction of the relationships between features of eligibility repre-
sentation and uses in turn derived from our limited sample, and is
subject to the same omissions and bias. Our characterization of
‘‘essential” representation primitives for eligibility criteria, and
our characterization of intended purposes of various prototype sys-
tems, derived from the literature sample itself, and therefore might
not be exhaustive. We did not control for the use, effectiveness,
evaluation, or any other measure of ﬁtness or success of any of
the systems which we have described in this review. Despite that
we did choose to speculate on future directions for eligibility crite-
ria representation formalisms, standards, and systems use, we
drew upon our expertise to support these speculations, but our
ideas have not yet been formally vetted with clinical research
informatics specialists, trialists, or systems developers.
5. Conclusion
We reviewed the diversity of the existing knowledge represen-
tation for eligibility criteria across three representation primitives,
which are expression language, codiﬁcation of medical concepts,
and modeling of patient data, as well as the variations in their in-
tended uses and content classiﬁcation. This review demonstrates
the complexity in eligibility criteria statements, which entails the
need for the combinational uses of multiple standards. We also
hope this conceptual framework can serve as an evaluation matrix
for future users or developers of computable eligibility criteria to
select relevant standards and to identify compatible representation
efforts toward collaborative standards development in this area.
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Appendix A
Table 1. Knowledge representation primitives for clinical research eligibility criteria (patient information model, clinical terminologies, expression language, and their standardization
status).
’Cita Brand Categorizations of criteria Common Data
Elements
Expression
language or query syntax
Representations of
patient data
Representations
of medical
concepts
Use cases Domain
[40,90] ONCOCIN No No Parameters-value
representation:
parameters represent the
attributes of patients,
drugs, tests, etc.
Implemented in Interlisp,
which provides symbol
manipulation capabilities
There two versions of
ONCOCIN, a main frame
and a workstation
versions. The workstation
version has a temporal
data representation and
query language [90]
The original patient
database in mainframe-
ONCOCIN used the time-
oriented databank (TOD)
model, where each value
has an associated time
stamp that denotes when
that value was observed.
The limitation of this
method is that it does not
appreciate meaningful
groupings of data. The
new version’s ETNET
provides date-free,
context-sensitive data
storage and retrieval
No Protocol-based
patient
management
Cancer
[20] AIDS2 Criteria are classiﬁed into three
categories: history, examination, and
tests based on importance in
determining eligibility status for the
protocol, on risk to the patient, and
on cost, which includes the cost of
the procedure and the clinician’s
time
No Three levels of KR: medical
concept level to represent
classes, probabilistic
belief-network level to
represent uncertainty
about criteria, and control
level to represent
procedural knowledge
No No Identifying
eligible patients
for trials
HIV
[65,48,26] T-Helper Criteria are classiﬁed into ﬁve groups
by objectiveness, variability, and
controllability of the underlying
clinical conditions: stable requisite,
variable routine, controllable,
subjective, and special. (p. 4 in
Samson’s paper)
No Eligibility criteria were
represented in as
instances of structured
templates whose syntax
allowing simple
comparison, arithmetic
combinations, arbitrary
conjunctions and
disjunctions;Each type of
criteria has templates used
for translating criteria to
database queries
A simple model that
deﬁnes time-stamped
parameter values and
interval-based events that
has attributes and values
No Identify eligible
patients for
trials
Generic
[30] OaSiS No No Prolog-based
representation for
parameters-values
predicates. (Rule-based)
Support for time-point-
based temporal
arguments, including both
relative and absolute
descriptions of time points
No No Protocol-based
patient
management
Cancer/
oncology
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’Cita Brand Categorizations of criteria Common Data
Elements
Expression
language or query syntax
Representations of
patient data
Representations
of medical
concepts
Use cases Domain
[9] Unnamed Criteria were divided into two
classes: one is static criteria
(diagnosis, age, sex), and the other is
temporal criteria (lab test, subjective
evaluation, symptoms)
No Bayesian network No No For ﬁltering
protocols based
on patient
characteristics
Generic
[27] Unnamed Criteria are categorized by ‘‘clinical
states” of signiﬁcance in cancer
domain
Not sure Criteria are represented in
frame-based systems,
where ‘‘Enumerated” data
types are supported so
that variables can only
take a value from a pre-
deﬁned list
No No external
standards, but
internally used
standard
naming
Criteria
representation
for clinical trial
authoring
Cancer
[12,11] Unnamed No No Enhanced Arden Syntax
(1) ‘‘Enumerated” data
types, where variables can
take on a value from a pre-
deﬁned list
(2) ‘‘Struct” data type and
a corresponding ‘‘dot
operator” that allow us to
assign speciﬁc attributes
to each variable or concept
(3) Primary time stamp
associated with data
variables; start and end
time to indicate intervals
(4) Clinical vocabulary
terms were selected from
UMLS and synonyms were
mapped
No UMLS For representing
eligibility
criteria with a
general syntax;
for ﬁltering
protocols based
on patient
characteristics.
Breast Cancer
[22] Unnamed No No Database query of selected
lab values
No No Recruiting
patients to trials
Hypoglycemia
[13,10] OncoDoc No No Decision tree, where
decision parameters aim
to describe patient states
No No Identify the best
trial for a
patient
Cancer
[19] EligWriter Clinical states,
similar to Rubin’s work
NCI’s CDE Ad hoc logical expressions No No Eligibility
determination
for protocols
Cancer
[91,42] Design-a-
Trial
No Not sure, no
speciﬁcation
of criteria in
papers
Textual representation No No Representation
of XML-based
clinical trials,
but not
computer-
executable
clinical trials
protocols
Generic
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[16,15,14] Unnamed The system supports three types of
questions: the ﬁrst type takes yes/no
response, the second is multiple
choice, and the third requires a
numeric answer
No The knowledge base
contains questions, tests,
and logical expressions
that represent eligibility
for each trial. Logical
expressions that can
represent equalities,
inequalities, set-element
relations, conjunctions,
and disjunctions. Variables
are deﬁned to represent
patient data. The
description of a medical
test includes its dollar cost
and list of questions that
can be answered based on
test results. Tests are
ordered by their cost and
among of information they
provided
No; data will be
entered by users
No To reduce the
cost of
eligibility
screening by
optimizing test
ordering
To ﬁlter trials or
protocols for
patients
through
interactive user
interface
Cancer
[41] Trial Bank Base-rule, recursive-rule No A rule-based
representation that
supports logical reasoning
over AND, OR, and
recursion
No No Formal methods
for representing
clinical trials
protocols
Generic
[17] OncoLink Questions are categorized as
demographics, contact information,
personal medical history, cancer
diagnosis, and treatments o date
Demographics,
contact
information,
personal
medical
history, cancer
diagnosis,
and
treatments to
date
Web-based questionnaire
‘‘Enumerated” data types
are supported
No No Interactive trials
search services
(ﬁltering
protocols); no
automatic
patient
matching
Cancer
[18] caMatch Criteria are categorized by diseases;
vocabulary-driven data entry (CDE’s
from caDSR)
Work with
HL7, CDISC,
and OMG
Provides a structured form
compliant with HL7
structured protocol
representation effort. For
patient to enter eligibility
information
Representation takes
parameter-value form: for
each data element, there
are a list of acceptable
values
Personal Health
Record
compliant with HL7
No Interactive trials
search services
(ﬁltering
protocols); no
automatic
patient
matching
Disease-
speciﬁc; data
collection and
matching rules
are
customized to
breast cancer;
other cancer in
the future
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’Cita Brand Categorizations of criteria Common Data
Elements
Expression
language or query syntax
Representations of
patient data
Representations
of medical
concepts
Use cases Domain
[8] ASPIRE Criteria are categorized by diseases Will use CDISC
elements
when deﬁned;
For breast
cancer criteria,
using NCI
elements from
caDSR
Representation takes
parameter-value form for
each data element, for
which there are a list of
acceptable values. Uses
HL7 Clinical Research
Functional Query
No Will use CDISC
terminology
when deﬁned
Interactive
Trials search
services
(ﬁltering
protocols); no
automatic
patient
matching
Disease-
speciﬁc: pan-
disease
[31,32] PROforma (1) Presence criteria Peleg 03 JAMIA,
p. 61
(2) Template-based criteria that look
for qualitative and quantitative
observations, medications, and other
types of EMR entities. P. 61: can
declaratively express simple
temporal constraints on these
entities of the form within an
interval of a time point
(3) First-order logic criteria, p. 61
(4) Temporal criteria. Difference in
TC: Asbru and EON supports
temporal abstraction, while GLIF
supports temporal operators of the
Arden Syntax logic grammar
No First-order logic language No No Generic
computer-based
clinical
guideline
representations
Generic
[33] Asbru XML-based criterion
language that allows
speciﬁcation of value set
or ranges, context, and
temporal extent of
parameters
Parameter + value pairs,
with context and time
annotation
No
[92,60] EON EON provides three
expression languages:
templates including
objects with certain
attributes, ﬁrst-order
logical language, and
temporal query language
VMR No
[39] PRODIGY PRODIGY: templates VMR READ code
[38,37] GUIDE SQL that supports some
ﬁrst-order logic criteria
An embedded health
record model
UMLS and
SNOMED
[35] GLIF3 No GELLO: an expression
language that deﬁnes the
syntax and semantics of
the decision criteria. It is
deﬁned by HL7 and CDISC
HL7 RIM (Reference
Information Model)
UMLS
[36] SAGE A rich set of criteria templates,
speciﬁed in p. 46. Examples include
N_ary_criterion, goal_criterion,
comparison_criterion,
temporal_comparison_criterion,
variable_comparison_criterion,
adverse_reaction_presence_criterion,
presence_criterion
No Structured templates (see
categorization of criteria)
that can be translated into
GELLO
VMR based on HL7 RIM SNOMED CT,
LOINC, NDF-RT
[28,25,23,24] Unnamed N/A N/A Web Ontology Language
(OWL)
VMR SNOMED CT Automated
mass-screening
of patients for
selected
protocols
through
automatic query
translation and
expansion
Generic
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[4] ERGO
(Eligibility
Rule
Grammar
and
Ontology)
Categorized by rules about
participant properties, interventions
done on participants, and participant
behaviors
No Structured templates that
model noun phrases,
expressions, and criteria;
with temporal and other
modiﬁcations, and
semantic relations, can be
recursively composed
VMR UMLS
SNOMED
MeSH
Representation
of computable
criteria for
eligibility
matching
Generic
[21,82] Unnamed No HL7 Virtual
Medical
Records (VMR)
Arden Syntax Medical
Logical Module (MLM);
each database query is a
VMR query (earlier it was
Data Access Modules
(DAM) and MED.
Not the most expressive
language in our set.
Primarily concept
mapping; no consideration
for temporal logic
VMR, speciﬁcally
attributes in class
‘‘Observations”
Intermountain
Healthcare’s
Healthcare Data
Dictionary
(1) Identifying
patients for
selected
protocols; (2)
automatic query
formulation
Generic;
identify
eligible
patients
[7] CRFQ Standardizing the parameters using
semantic signiﬁers with these
parameter types
(1) Demographic Data
(2) Patient Disease Historical Data
(3) Disease MetaData
(4) Disease Data
(5) Protol Listings
(6) I_E Criteria
(7) Patient Preference Data
ASPIRE as the
source for core
data elements
Structured representation
by HL7
HL7 V3 data types (1)
Interoperability
of all
applications
using
computer-based
criteria: (2)
ﬁltering
protocols or (3)
identify eligible
patients
Disease-
speciﬁc
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